by Mybiogate | Dec 1, 2020 | Industry Research
Author: HE Sheng Endocrine therapy is a first-line therapy for prostate cancer, with gonadotropin-releasing hormones (GnRH) occupying a strong position. Although the incidence of prostate cancer in China is much lower than that in the United States, with life... by Mybiogate | Nov 20, 2020 | Industry Research
Author: HE Sheng Migraine is a common neurological disease, which can be chronic. According to the Migraine Research Foundation, symptoms include a severe throbbing recurring pain, usually on one side of the head and at least one of the following: “visual... by Mybiogate | Nov 17, 2020 | Industry Research
Author: Ginger Ding Following PD-(L)1, high-end players have quickly joined the race to develop the new star T cell immunoreceptors with immunoglobulin and ITIM domain (TIGIT). Roche, BMS, Merck and other international pharmaceutical companies have all entered.... by Mybiogate | Nov 13, 2020 | Industry Research
Author: MJ Yuan Part 2 of a series on the Analgesic Drug Market. Part 1 focused on China while Part 2 takes a global perspective. Opioid Abuse is a Serious Problem, A New Trend in Non-Opioid Medication Begins In 1996, Purdue Pharmaceuticals, run by the Sackler... by Mybiogate | Nov 10, 2020 | Industry Research
Author: Ginger Ding “Reflections on CRISPR’s Potential (Part 1)” explores the bottlenecks and challenges of CRISPR clinical applications and uses the case study of CRISPR Therapeutics and Editas to interpret the corporate strategies of different... by Mybiogate | Nov 6, 2020 | Industry Research
Author: Youwen Dai In China, the rapid growth of the analgesic market is second only to oncology drugs. As an example, Yangtze River’s dezocine is an analgesic acting as a κ partial agonist and μ partial agonist. It leads the analgesics market in...